|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.53 EUR | +1.03% |
|
-2.38% | +7.08% |
| 07-24 | European Stocks Close Higher Friday; Eurozone Private Sector Expands in July | MT |
| 07-24 | GSK : JP Morgan reiterates its Sell rating | ZD |
| Market Cap | 76.44B 102B 89.56B 83.3B 144B 9,829B 146B 990B 388B 4,821B 382B 374B 16,687B | P/E 2026 * |
12.1x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 91.91B 122B 108B 100B 173B 11,818B 175B 1,190B 466B 5,797B 459B 450B 20,064B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.49x |
| Free-Float |
92.29% | Yield 2026 * |
3.63% | Yield 2027 * | 3.81% |
Last Transcript: GSK plc
| 1 day | +1.03% | ||
| 1 week | -2.38% | ||
| Current month | -2.04% | ||
| 1 month | -0.66% | ||
| 3 months | -6.01% | ||
| 6 months | +8.47% | ||
| Current year | +7.08% |
| 1 week | 21.87 |  | 22.68 |
| 1 month | 21.87 | | 23.91 |
| Current year | 20.34 | | 26.14 |
| 1 year | 15.66 | | 26.14 |
| 3 years | 14.48 | | 26.14 |
| 5 years | 14.48 | | 27.23 |
| 10 years | 14.48 | | 27.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
| Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 68 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | -2.38% | - | - | 101B | |
| +0.86% | +2.30% | +49.71% | +158.86% | 1,057B | |
| +1.59% | +5.37% | +55.77% | +54.77% | 624B | |
| +0.95% | +1.95% | +36.11% | +80.44% | 454B | |
| +1.60% | +7.09% | +35.90% | +29.32% | 341B | |
| -0.60% | +2.95% | +36.28% | +39.04% | 297B | |
| -0.14% | +0.33% | +18.70% | +17.64% | 262B | |
| +0.09% | -4.53% | -27.60% | -42.19% | 215B | |
| +1.22% | +1.20% | +21.61% | +60.14% | 201B | |
| -1.18% | -5.13% | +13.87% | +60.35% | 162B | |
| Average | +0.40% | +0.77% | +26.70% | +50.93% | 401.55B | |
| Weighted average by Cap. | +0.29% | +1.57% | +36.61% | +76.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.91B 45.16B 39.73B 36.95B 63.67B 4,360B 64.72B 439B 172B 2,139B 169B 166B 7,402B | 35.65B 47.49B 41.77B 38.85B 66.94B 4,584B 68.04B 462B 181B 2,248B 178B 174B 7,783B |
| Net income | 6.47B 8.61B 7.58B 7.05B 12.15B 832B 12.34B 83.73B 32.81B 408B 32.32B 31.64B 1,412B | 6.92B 9.22B 8.11B 7.54B 13B 890B 13.21B 89.61B 35.11B 437B 34.59B 33.86B 1,511B |
| Net Debt | 15.47B 20.6B 18.12B 16.86B 29.05B 1,989B 29.52B 200B 78.47B 976B 77.29B 75.67B 3,377B | 12.47B 16.61B 14.62B 13.59B 23.42B 1,604B 23.81B 161B 63.28B 787B 62.33B 61.03B 2,723B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €22.53 | +1.03% | 32,769 |
| 26-07-23 | €22.30 | -0.54% | 15,187 |
| 26-07-22 | €22.42 | +0.95% | 36,768 |
| 26-07-21 | €22.21 | +0.14% | 83,765 |
| 26-07-20 | €22.18 | -1.81% | 70,448 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
Select your edition
All financial news and data tailored to specific country editions
